US 8518966
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
granted A61PA61P1/00A61P25/04
Quick answer
US patent 8518966 (Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists) held by Theravance, Inc. expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/00, A61P25/04